U.S. National Institutes of Health scientists played "a major role" in developing Moderna's Covid-19 vaccine and the agency intends to defend its claim as co-owner of patents on the shot, NIH Director Dr. Francis Collins told Reuters on Wednesday.
In a story first reported by the New York Times on Tuesday, Moderna excluded three NIH scientists as co-inventors of a central patent for the company's multibillion-dollar Covid-19 vaccine in its application filed in July. Moderna expects 2021 sales of $15 billion to $18 billion from the Covid-19 vaccine - its first and only commercial product - and up to $22 billion next year.
"But we are not done. Clearly this is something that legal authorities are going to have to figure out," he said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: